This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Indian frankincense
- DrugBank Accession Number
- DB14275
- Background
Indian frankincense is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Boswellia Glabra Resin
- Boswellia Serrata
- Boswellia Serrata Extract
- Boswellia Serrata Gum
- Boswellia Serrata Gum Extract
- Boswellia Serrata Preparation
- Boswellia Serrata Resin
- Boswellia Serrata Resin Extract
- Boswellia Serrata Roxb. Ex Colebr. Oleo-gum-resin
- Indian Frankincense Oleo-gum-resin
- Indian Frankincense Resin
- Indian Olibanum
- Indian Olibanum Oleo-gum-resin
- Indian Olibanum Resin
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ACTS38 BoswelliaGel Indian frankincense (1.2 g/100mL) + Centella asiatica (0.01 g/100mL) + Sodium hyaluronate (0.01 g/100mL) + N-Acetylglucosamine (0.1 g/100mL) Gel Topical A-Lot Biologics Inc 2022-09-07 Not applicable US 
ACTS38 BoswelliaGel (100ml) Indian frankincense (1.2 g/100mL) + Centella asiatica (0.01 g/100mL) + Sodium hyaluronate (0.01 g/100mL) + N-Acetylglucosamine (0.1 g/100mL) Gel Topical A-Lot Biologics Inc 2022-10-23 Not applicable US Noxicare Indian frankincense (10 mL/100mL) + Ginger oil (10 mL/100mL) + Lipoic acid (10 mL/100mL) + Ocimum tenuiflorum top (10 mL/100mL) + Rosemary oil (10 mL/100mL) + Turmeric oil (10 mL/100mL) + Willow bark (10 mL/100mL) Cream Topical Truceuticals, Llc 2010-03-01 2010-07-10 US Tru-micin Indian frankincense (0.01 g/100mL) + Ginger (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) + Turmeric (0.01 g/100mL) Lotion Topical Truceuticals, Llc 2011-05-25 2013-08-14 US Tru-micin Indian frankincense (0.01 g/100mL) + Ginger (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) + Turmeric (0.01 g/100mL) Lotion Topical Dispensing Solutions, Inc. 2011-05-25 2013-08-14 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ACTS38 BoswelliaGel Indian frankincense (1.2 g/100mL) + Centella asiatica (0.01 g/100mL) + Sodium hyaluronate (0.01 g/100mL) + N-Acetylglucosamine (0.1 g/100mL) Gel Topical A-Lot Biologics Inc 2022-09-07 Not applicable US ACTS38 BoswelliaGel (100ml) Indian frankincense (1.2 g/100mL) + Centella asiatica (0.01 g/100mL) + Sodium hyaluronate (0.01 g/100mL) + N-Acetylglucosamine (0.1 g/100mL) Gel Topical A-Lot Biologics Inc 2022-10-23 Not applicable US Tru-micin Indian frankincense (0.01 g/100mL) + Ginger (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) + Turmeric (0.01 g/100mL) Lotion Topical Truceuticals, Llc 2011-05-25 2013-08-14 US Tru-micin Indian frankincense (0.01 g/100mL) + Ginger (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) + Turmeric (0.01 g/100mL) Lotion Topical Dispensing Solutions, Inc. 2011-05-25 2013-08-14 US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4PW41QCO2M
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 485858
- Wikipedia
- Boswellia_serrata
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Terminated Treatment Central Nervous System Neoplasm / Edema of the cerebrum 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Cream Topical Lotion Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53